A study from the Hebrew University of Jerusalem and the Children’s Hospital in Boston has shed new light on the properties of induced pluripotent stem cells (iPS cells), reporting evidence that they may not be able to replace embryonic stem cells in some research and medical applications. Their conclusion is that research using both types of pluripotent human stem cells is crucial. Read More





